Key Insights

Highlights

Treatment Research

1 treatments under study, led by Septal Scoring Along Midline Endocardium

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

100.0%

1 terminated out of 1 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

1 of 0 completed with results

Key Signals

1 with results0

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Terminated1

Clinical Trials (1)

Showing 1 of 1 trials
NCT06269640Not ApplicableTerminated

NHLBI SESAME (SEptal Scoring Along Midline Endocardium) Early Feasibility Study

Showing all 1 trials

Research Network

Common Treatments

  • Septal Scoring Along Midline Endocardium1

Active Sponsors

  • National Heart, Lung, and Blood Institute (NHLBI)1

Top Investigators

Related Conditions

  • Aortic Valve Stenosis1
  • Hypertrophic Cardiomyopathy1
  • Mitral Valve Disease1

Activity Timeline